Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.

Autor: Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJ, AV45-A11 Study Group, Doraiswamy, P Murali, Sperling, Reisa A, Coleman, R Edward
Zdroj: Neurology; 10/16/2012, Vol. 79 Issue 16, p1636-1644, 9p
Databáze: Supplemental Index